Nanoparticles could deliver drugs to the brain
For patients with malignant brain tumors, the prognosis remains dismal. With the most aggressive treatments available, patients are usually only expected to live about 14 months after a diagnosis.
This is because, chemotherapy, the most common form of treatment for cancer, is uniquely challenging for brain tumor patients. The delicate organ in our skulls is protected by a network of vessels and tissue called the blood-brain barrier that keeps most foreign substances out. Furthermore, chemotherapy drugs can cause significant damage to the rest of the body if they are not able to target the tumor in a pharmacologically significant dose.
These challenges have plagued scientists for years, but a team of researchers for Yale School of Medicine and Beijing Normal University just published a breakthrough study detailing a new method that offers a promise at treatment. The solution? Nanoparticles.
Nanoparticles, particles that are smaller than wavelengths of visible light and can only be seen under a special microscope, have the potential to pass through the blood-brain barrier. They can also carry drugs to targeted areas of the body, reducing the side effects on the rest of the body. But previous nanoparticles were very complex and not very efficient in penetrating in the brain.
This most recent paper, published in Nature Biomedical Engineering on March 30, 2020, describes a small carbon nanoparticle engineered by the two labs that could both deliver chemotherapy drugs across the blood-brain barrier and mark tumor cells with fluorescence in mice. What’s more, this nanoparticle is incredibly simple—made up of only one single compound.
We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.
“The major problems we’ve solved is to improve the delivery efficiency and specificity of nanoparticles,” says Jiangbing Zhou, PhD, associate Professor of Neurosurgery and of Biomedical Engineering at Yale School of Medicine. “We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.”
The GPS-like targeting occurs because the nanoparticles engineered to be recognized by a molecule called LAT1, which is present in the blood-brain barrier as well as many tumors, but not in most other normal organs. As a result, chemotherapy drugs can be loaded on the dots and target tumors while barely affecting the rest of the body. The nanoparticles gain entry to the brain because they’ve been engineered to look like amino acids, which are allowed past the blood-brain barrier as nutrients.
The nanoparticles have wider implications than drug delivery. They can be stimulated to emit a fluorescence, which helps surgeons locate tumor to remove with greater accuracy.
Still, there’s a long road ahead before this research can be applied in a clinical setting, says Dr. Zhou. “It takes a long time before the technology can be translated into clinical applications,” he says. “But this finding suggests a new direction for developing nanoparticles for drug delivery to the brain by targeting LAT1 molecules.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Brain cancer treatment
- New MRI nanotechnology designed to precisely image aggressive brain tumors
A novel technology designed to precisely image aggressive brain cancers and guide treatment is being developed by the University of South Australia and Australian cancer diagnostic company, Ferronova, ...
- Dorset veteran battles brain cancer
Specifically, he has glioblastoma, the same type of brain cancer that killed Beau Biden ... Doctors told him he might have as long as 17 months and that his treatment has a success rate of one in nine ...
- New tumour-injecting gel to treat brain cancer revealed
Mahidol University has introduced biopolymer gel, a new drug delivery system, to effectively treat brain cancer patients while also reducing the cost.
- Researchers pursue a new way to use milk for delivering cancer-fighters to the brain
In health care, perhaps no word sends a more chilling message than "cancer." Brain tumors, for example, prove especially resistant to current treatments. Only 5% of patients with that condition ...
- Does milk hold the key to beating brain cancer?
Zempleni said: "Such an animal would secrete milk exosomes conducive to maximal delivery of RNA therapeutics to brain tumors in human cancer patients." The drugs industry is already using 'biopharming ...
Go deeper with Google Headlines on:
Brain cancer treatment
Go deeper with Bing News on:
Carbon nanoparticle drug delivery
- The promise of RNA medicine is targeted and personalized
The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.
- Nanodelivery Strategies in Cancer Chemotherapy
Here, we present cancer drug delivery strategies that ... solid lipid nanoparticles, polymeric nanoparticles, dendrimers, carbon nanotubes and magnetic nanoparticles. As the cardinal features ...
- Nanomaterials news
Russian scientists have synthesized a new ultra-hard material consisting of scandium containing carbon. It consists ... University have shown how silicon nanoparticles can become trapped inside ...
- Renewable Solvent Suited for Drug-Delivery Systems and Medical Implants
Biotech company Circa Group reports that a study using its renewable solvent Cyrene found that high-purity nanoparticles can be produced, opening up opportunities to use the material as a ...
- Carbon Nanohorns: Potential Nonviral Carriers for Gene and Drug Delivery
Michael Berger over at the nanoBLOG takes a look at the work of scientists to develop carbon nanohorn (CNH), a member of the fullerene family, into a delivery vehicle for various kinds of therapies.